Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/14/20
End: 11/01/22
Due: 11/01/23
Phase: N/A
Priority: Normal
Start: 01/15/19
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma | NCT04565327 | Zhen Wang, MD | user2@example.com | None | 2020-08-14 | 2022-11-01 | 2023-11-01 | - | - | 2025-07-14 |
| Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors | NCT04258462 | Zhen Wang, MD | user2@example.com | None | 2019-01-15 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |